577 related articles for article (PubMed ID: 27001906)
1. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.
Hyun J; Wang S; Kim J; Rao KM; Park SY; Chung I; Ha CS; Kim SW; Yun YH; Jung Y
Nat Commun; 2016 Mar; 7():10993. PubMed ID: 27001906
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
3. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
Yu F; Fan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.
Ma L; Yang X; Wei R; Ye T; Zhou JK; Wen M; Men R; Li P; Dong B; Liu L; Fu X; Xu H; Aqeilan RI; Wei YQ; Yang L; Peng Y
Cell Death Dis; 2018 Jun; 9(7):718. PubMed ID: 29915227
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened.
Lu CH; Hou QR; Deng LF; Fei C; Xu WP; Zhang Q; Wu KM; Ning BF; Xie WF; Zhang X
Dig Dis Sci; 2015 Jul; 60(7):2038-48. PubMed ID: 25686745
[TBL] [Abstract][Full Text] [Related]
6. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7.
Zhu J; Zhang Z; Zhang Y; Li W; Zheng W; Yu J; Wang B; Chen L; Zhuo Q; Chen L; Zhang J; Liu J
Biochem Biophys Res Commun; 2018 Jan; 496(1):176-183. PubMed ID: 29307832
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
Sun J; Zhang H; Li L; Yu L; Fu L
Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-361 suppresses the biological processes of hepatic stellate cells in HBV-relative hepatic fibrosis by NF-kappaB p65.
Yu G; Mu H; Zhou H; Fang F; Cui Y; Wu Q; Xiong Q; Li H
Cells Dev; 2021 Sep; 167():203711. PubMed ID: 34216805
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N
Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.
Li F; Ma N; Zhao R; Wu G; Zhang Y; Qiao Y; Han D; Xu Y; Xiang Y; Yan B; Jin J; Lv G; Wang L; Xu C; Gao X; Luo S
J Cell Mol Med; 2014 Jun; 18(6):966-74. PubMed ID: 24801603
[TBL] [Abstract][Full Text] [Related]
15. MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.
Ji F; Wang K; Zhang Y; Mao XL; Huang Q; Wang J; Ye L; Li Y
J Cell Biochem; 2019 Mar; 120(3):4573-4581. PubMed ID: 30368874
[TBL] [Abstract][Full Text] [Related]
16. Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells.
Chen X; Zhang D; Wang Y; Chen K; Zhao L; Xu Y; Jiang H; Wang S
Cell Death Dis; 2020 May; 11(5):402. PubMed ID: 32467578
[TBL] [Abstract][Full Text] [Related]
17. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p.
Kim J; Lee C; Shin Y; Wang S; Han J; Kim M; Kim JM; Shin SC; Lee BJ; Kim TJ; Jung Y
Mol Ther; 2021 Apr; 29(4):1471-1486. PubMed ID: 33348053
[TBL] [Abstract][Full Text] [Related]
18. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
[TBL] [Abstract][Full Text] [Related]
19. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway.
Yang X; Ma L; Wei R; Ye T; Zhou J; Wen M; Men R; Aqeilan RI; Peng Y; Yang L
Signal Transduct Target Ther; 2020 Jun; 5(1):75. PubMed ID: 32499481
[TBL] [Abstract][Full Text] [Related]
20. Leptin up-regulates microRNA-27a/b-3p level in hepatic stellate cells.
Li Z; Ji L; Su S; Zhu X; Cheng F; Jia X; Zhou Q; Zhou Y
Exp Cell Res; 2018 May; 366(1):63-70. PubMed ID: 29548749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
